Pharmaceuticals (511) | Note Agreements (511)
Browse by Company
-
4Front Ventures Corp. (2)
-
Acasti Pharma Inc. (8)
-
Acer Therapeutics Inc. (3)
-
ACURA PHARMACEUTICALS, INC (8)
-
Adamis Pharmaceuticals Corp (3)
-
Akers Biosciences, Inc. (1)
-
ALIMERA SCIENCES INC (1)
-
AmeriCann, Inc. (2)
-
Angion Biomedica Corp. (2)
-
Applied BioSciences Corp. (3)
-
APRICUS BIOSCIENCES, INC. (3)
-
Aquestive Therapeutics, Inc. (2)
-
Artemis Therapeutics, Inc. (3)
-
Assertio Therapeutics, Inc (3)
-
AXIM BIOTECHNOLOGIES, INC. (3)
-
AYTU BIOSCIENCE, INC (1)
-
Baudax Bio, Inc. (1)
-
Bespoke Extracts, Inc. (1)
-
Big Rock Partners Acquisition Corp. (2)
-
BioPharmX Corp (1)
-
Blue Water Acquisition Corp. (2)
-
BODY & MIND INC. (4)
-
Boston Therapeutics, Inc. (4)
-
Canbiola, Inc. (15)
-
Cannabics Pharmaceuticals Inc. (4)
-
CANNAPHARMARX, INC. (1)
-
CARDAX, INC. (6)
-
Celexus, Inc (4)
-
Cerecor Inc. (2)
-
Charlotte's Web Holdings, Inc. (1)
-
CHINA PHARMA HOLDINGS, INC. (1)
-
Cingulate Inc. (7)
-
Clever Leaves Holdings Inc. (3)
-
CLS Holdings USA, Inc. (3)
-
ContraVir Pharmaceuticals, Inc. (1)
-
COSMO VENTURES INC (8)
-
Cure Pharmaceutical Holding Corp. (8)
-
Endexx Corp (2)
-
Eton Pharmaceuticals, Inc. (2)
-
Evofem Biosciences, Inc. (6)
-
Evolus, Inc. (3)
-
Exactus, Inc. (7)
-
GB SCIENCES INC (18)
-
GREEN HYGIENICS HOLDINGS INC. (5)
-
Green Thumb Industries Inc. (2)
-
GridIron BioNutrients, Inc. (7)
-
IMAGING3 INC (19)
-
INNOVATE BIOPHARMACEUTICALS, INC. (6)
-
IntelGenx Technologies Corp. (3)
-
Intersect ENT, Inc. (1)
-
Jaguar Health, Inc. (7)
-
Johnson & Johnson (1)
-
Journey Medical Corp (1)
-
Kannalife Inc (4)
-
KEMPHARM, INC (4)
-
Level Brands, Inc. (1)
-
Lilly (Eli) & Co. (11)
-
Mallinckrodt (1)
-
Marijuana Co of America, Inc. (3)
-
Medicine Man Technologies, Inc. (7)
-
MedMen Enterprises, Inc. (3)
-
Merck (15)
-
MICROCHANNEL TECHNOLOGIES CORP (24)
-
MJ Holdings, Inc. (7)
-
MYnd Analytics, Inc. (14)
-
Neos Therapeutics, Inc. (4)
-
Neuralstem, Inc. (1)
-
NewBridge Global Ventures, Inc. (4)
-
NEXIEN BIOPHARMA, INC. (4)
-
Notis Global, Inc. (4)
-
NovaBay Pharmaceuticals, Inc. (5)
-
Novan, Inc. (2)
-
OCULAR THERAPEUTIX, INC (1)
-
One World Pharma, Inc. (10)
-
OPIANT PHARMACEUTICALS, INC. (1)
-
OptiNose, Inc. (1)
-
Osmotica Pharmaceuticals plc (1)
-
Panacea Acquisition Corp (3)
-
Petros Pharmaceuticals, Inc. (2)
-
Pharmagreen Biotech Inc. (4)
-
Phathom Pharmaceuticals, Inc. (2)
-
PLAYERS NETWORK (1)
-
Processa Pharmaceuticals, Inc. (3)
-
ProPhase Labs, Inc. (3)
-
PROVECTUS BIOPHARMACEUTICALS, INC. (2)
-
QUANTA INC (4)
-
Rani Therapeutics Holdings, Inc. (1)
-
Recro Pharma, Inc. (2)
-
RespireRx Pharmaceuticals Inc. (15)
-
Revance Therapeutics, Inc. (1)
-
SCYNEXIS INC (2)
-
SenesTech, Inc. (1)
-
Target Group Inc. (1)
-
TAURIGA SCIENCES, INC. (41)
-
Tenzing Acquisition Corp. (8)
-
Terra Tech Corp. (23)
-
TETRAPHASE PHARMACEUTICALS INC (1)
-
Textmunication Holdings, Inc. (12)
-
Theravance Biopharma, Inc. (1)
-
Tilray, Inc. (2)
-
Trulieve Cannabis Corp. (2)
-
United Cannabis Corp (2)
-
Upjohn Inc (1)
-
Vallon Pharmaceuticals, Inc. (4)
-
Virpax Pharmaceuticals, Inc. (15)
-
VIVUS INC (1)
-
XERIS PHARMACEUTICALS INC (1)
-
Zomedica Pharmaceuticals Corp. (1)
Recent Contracts
-
Convertible Promissory Note, dated June 27, 2022
(Textmunication Holdings, Inc., Filed With SEC on July 1, 2022)
-
Second Promissory Note Modification Agreement between Registrant and 483 Management, LLC dated March 4, 2022
(GB SCIENCES INC, Filed With SEC on June 30, 2022)
-
Promissory Note dated December 31, 2021 made by AJE Management, LLC in favor of Registrant
(GB SCIENCES INC, Filed With SEC on June 30, 2022)
-
Form of Senior Secured Convertible Note
(INNOVATE BIOPHARMACEUTICALS, INC., Filed With SEC on June 30, 2022)
-
Note Modification Agreement
(MJ Holdings, Inc., Filed With SEC on June 21, 2022)
-
Convertible Promissory Note issued to Trillium Partners L.P. dated November 12, 2021
(QUANTA INC, Filed With SEC on June 16, 2022)
-
Investor Note
(Canbiola, Inc., Filed With SEC on June 15, 2022)
-
Form of Convertible Note due September 1, 2023, issued and owing by the Company to HTI
(Tilray, Inc., Filed With SEC on June 14, 2022)
-
Promissory Note, dated January 18, 2022, by Metuchen Pharmaceuticals LLC in favor or VIVUS LLC, a Delaware limited liability company
(Petros Pharmaceuticals, Inc., Filed With SEC on May 16, 2022)
-
Promissory Note date January18,2022 issued by registrant to Soomi Niihara
(MYnd Analytics, Inc., Filed With SEC on May 13, 2022)
